These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 17278788)

  • 21. Catecholaminergic Polymorphic Ventricular Tachycardia.
    Wall JJ; Iyer RV
    Pediatr Emerg Care; 2017 Jun; 33(6):427-431. PubMed ID: 28570361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable cardioverter-defibrillators: not the ultimate gold standard for gauging therapy of VT/fibrillation.
    Singh BN
    Am J Cardiol; 1994 Jun; 73(16):1211-3. PubMed ID: 8203341
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.
    Stevenson WG; Chaitman BR; Ellenbogen KA; Epstein AE; Gross WL; Hayes DL; Strickberger SA; Sweeney MO; ;
    Circulation; 2004 Dec; 110(25):3866-9. PubMed ID: 15611390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.
    Khairy P
    Heart; 2016 Nov; 102(21):1703-1709. PubMed ID: 27250216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
    Tung R; Swerdlow CD
    Circulation; 2009 Sep; 120(10):825-7. PubMed ID: 19704090
    [No Abstract]   [Full Text] [Related]  

  • 27. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
    [No Abstract]   [Full Text] [Related]  

  • 28. Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest?
    Zipes DP
    Circulation; 1995 Apr; 91(8):2115-7. PubMed ID: 7697837
    [No Abstract]   [Full Text] [Related]  

  • 29. [Primary prevention of sudden cardiac death].
    Burkhard-Meier C; Hoppe UC
    Dtsch Med Wochenschr; 2003 Nov; 128(48):2547-52. PubMed ID: 14648439
    [No Abstract]   [Full Text] [Related]  

  • 30. Aborted sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Casey SA; Almquist AK
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):263. PubMed ID: 10090231
    [No Abstract]   [Full Text] [Related]  

  • 31. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).
    Fuster V; Rydén LE; Cannom DS; Crijns HJ; Curtis AB; Ellenbogen KA; Halperin JL; Le Heuzey JY; Kay GN; Lowe JE; Olsson SB; Prystowsky EN; Tamargo JL; Wann S; ; ; ;
    Eur Heart J; 2006 Aug; 27(16):1979-2030. PubMed ID: 16885201
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
    Prystowsky EN
    Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The implantable defibrillator. From concept to clinical reality.
    Jordaens L
    Adv Cardiol; 1996; 38():1-168. PubMed ID: 8955754
    [No Abstract]   [Full Text] [Related]  

  • 34. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.
    Adabag AS; Maron BJ
    Ann Noninvasive Electrocardiol; 2007 Apr; 12(2):171-80. PubMed ID: 17593187
    [No Abstract]   [Full Text] [Related]  

  • 35. Ventricular arrhythmias and sudden cardiac death.
    John RM; Tedrow UB; Koplan BA; Albert CM; Epstein LM; Sweeney MO; Miller AL; Michaud GF; Stevenson WG
    Lancet; 2012 Oct; 380(9852):1520-9. PubMed ID: 23101719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ventricular arrhythmias. Preventing sudden death with drugs and ICD devices.
    Doherty JU; Fuchs S; Tecce MA
    Geriatrics; 2000 Aug; 55(8):26-8, 31-2, 35-6. PubMed ID: 10953684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Automatic implantable defibrillators].
    Licourt J; Orvin MA
    Soins; 2003 Jan; Spec No 1(1):12-5. PubMed ID: 12621698
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment approaches for patients with sustained VT/VF.
    Mitchell LB; Roy D
    Can J Cardiol; 2000 Jun; 16 Suppl C():23C-5C. PubMed ID: 10887274
    [No Abstract]   [Full Text] [Related]  

  • 40. Implantable cardioverter defibrillators in the United States: understanding the benefits and limitations of implantable cardioverter defibrillator therapy based on clinical trial results.
    Gottlieb C; Callans DJ; Marchlinski F
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 1):2016-20. PubMed ID: 9826851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.